ArticleCancers2020

Epithelial Transfer of the Tyrosine Kinase Inhibitors Erlotinib, Gefitinib, Afatinib, Crizotinib, Sorafenib, Sunitinib, and Dasatinib: Implications for Clinical Resistance.

Richard J Honeywell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.